Michael Kane
Chief Executive Officer
Michael Kane is the Chief Executive Officer at Tergus Pharma. Mr. Kane’s career includes over 20 years of experience in leading pharmaceutical and health & wellness businesses across Rx, generic OTC, and infant formula regulatory segments in CEO, COO, and other senior operating roles. This experience spanned topical, soft gel, tablet, powder, and liquid dosage forms. Most recently, he was the COO at the International Vitamin Corporation. Previous to that Mr. Kane was an Operating Partner with Blue Point Capital Partners, and CEO of a topical CDMO focused in Rx, Generic, OTC, and Dx Dispensed products. Prior to his involvement with privately held enterprises, he held a series of progressive leadership roles with Novartis and Abbott Laboratories and has worked with such leading brands as Similac®, Ensure®, Gerber®, Selsun Blue® and Murine®/Clear Eyes®. Mr. Kane currently serves as an Advisor for the University of Notre Dame’s Mendoza School of Business MBA program. Mr. Kane earned his MBA from the University of Notre Dame and a Bachelor of Science in Business Management from Indiana University of Pennsylvania. He also served as a Captain in the United States Marine Corps.
Peter Geiger
Chief Financial Officer
Peter Geiger is the Chief Financial Officer at Tergus Pharma. Mr. Geiger brings Tergus a depth of expertise in providing financial and operational leadership to a diverse portfolio of companies from start-ups to a $240M-pharmaceutical contract manufacturing organization. His leadership experience encompasses guiding companies through venture capital funding, mergers, acquisitions, and day-to-day operational strategic management for U.S. and international markets. His career is steeped in medicine and pharmaceuticals, including time spent as a neurochemistry research analyst for the National Institutes of Health’s National Institute of Neurological Disorders and Stroke(NINDS). Before joining Tergus, Mr. Geiger served as COO and CFO for Perfusio, was VP of Finance at DSM where he led the financial integration of the CDMO business into Patheon following the merger of the two. Mr. Geiger earned his MBA from The Wharton School of the University of Pennsylvania and a Bachelor of Science in Behavioral Neuroscience from Lehigh University.
Vijendra Nalamothu, Ph.D.
Chief Science Officer
Dr. Vijendra Nalamothu is the Founder, Executive Chairman, & CSO of Tergus Pharma. Dr. Nalamothu holds a doctorate in Pharmaceutics from the University of the Sciences’ Philadelphia College of Pharmacy. His efforts over the past 26 years in various dermatological companies have led to many commercial products in the market today. He worked at Sanofi-Aventis Worldwide Dermatology (Dermik) as the Head of the Early Compound Assessment and Preclinical Group. He also served as Global Head of Dermatology R&D at Promius Pharma, a wholly owned subsidiary of Dr. Reddy’s Laboratories, where he spearheaded the development of specialty branded dermatological products from concept to commercialization. He has successfully taken Tergus Pharma from a small R&D facility to a 100,000 square foot commercial manufacturing facility with industry-leading capabilities. His passion is to develop products that speak for themselves, leading him to co-found Tergus and shepherd the company to its industry-leading position in the marketplace.
Naomi Seresinhe
SVP of Business Operations
Naomi Seresinhe is the Senior Vice President, Business Operations at Tergus Pharma. She has over 20 years of operational experience in the biotechnology, banking and auto manufacturing industries. She brings a proven ability to lead strategic and tactical cross-functional initiatives including operational centers, customer service, financial reporting, and inventory control. Ms. Seresinhe plays a critical role in helping Tergus identify and implement opportunities to improve operational performance and customer experiences. Before coming to Tergus, she spent over a decade in roles of increasing responsibility at Cytovance Biologics where she ultimately led the Marketing, Business Development and Program Management Teams, and negotiated several customer MSAs and strategic partnership deals with industry leaders. Ms. Seresinhe earned her MBA from City University of Seattle and a Bachelor of Science in Microbiology from the University of Saskatchewan.
John Simonick
VP of Quality Assurance
John Simonick is Associate VP of Quality Assurance for Tergus Pharma. He has over 20 years of experience in the CDMO space and has worked with a variety of dosage forms including semi-solids, tablets, capsules, transdermal patches, oral liquids, suspensions, and aerosols. These included human drugs, veterinary drugs, devices, and drug/device combination products. Mr. Simonick spent several years on the manufacturing side, having supervised the manufacture and filling of Chapstick®. Previously, Mr. Simonick was QA Site Director for Sovereign Pharmaceuticals. Before that, he was VP of QA/QC at Mission Pharmacal. He has held quality leadership roles at many other pharmaceutical companies, including Watson Pharmaceuticals, DPT Laboratories, and Medeva Pharmaceuticals. Mr. Simonick received a Bachelor of Science in Chemistry and Math from MacMurray College.